The DOI matches its Crossref record.
HD39 (B3), a B lineage-restricted antigen whose cell surface expression is limited to resting and activated human B lymphocytes.
Abstract
The B cell-restricted antigen HD39, whose cell surface expression is limited to resting and activated human B lymphocytes, is described in this report. The monoclonal antibody HD39 detects a two-chain glycoprotein with apparent molecular weights of 130,000 and 140,000. During B cell ontogeny, HD39 is first expressed in the cytoplasm of bone marrow derived pre-B cells, then appears on the cell surface of sIgM+ B cells, and finally on the majority of sIgM+ sIgD+ resting B cells. After activation in vitro, the expression of HD39 on the cell surface first increases, and then the antigen is lost as cells begin to differentiate. HD39 is weakly expressed on very few non-T cell ALL and B cell CLL, on approximately 50% of B cell lymphomas, and not on Waldenström's macroglobulinemias and myelomas. In contrast, it is strongly expressed on all hairy cell leukemias. Its limited cell surface expression in B cell ontogeny suggests that HD39 may be important in the events that regulate the activation of the human resting B lymphocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Hyperresponsive B Cells in CD22-Deficient Mice
O'Keefe, T. L., Williams, G. T., Davies, S. L., & Neuberger, M. S. (1996) · Science · doi:10.1126/science.274.5288.798 · Cited by 532
Siglecs—the major subfamily of I-type lectins
Varki, A., & Angata, T. (2006) · Glycobiology · doi:10.1093/glycob/cwj008 · Cited by 518
Immune regulation by the ST6Gal sialyltransferase
Hennet, T., Chui, D., Paulson, J. C., & Marth, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4504 · Cited by 366
Stamenkovic, I., Sgroi, D., Aruffo, A., Sy, M. S., & Anderson, T. (1991) · Cell · doi:10.1016/0092-8674(91)90036-x · Cited by 343
Damle, R. N. (2002) · Blood · doi:10.1182/blood.v99.11.4087 · Cited by 341
O'Keefe, T. L., Williams, G. T., Batista, F. D., & Neuberger, M. S. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.8.1307 · Cited by 320
Powell, L. D., & Varki, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.24.14243 · Cited by 312
CD22, A B LYMPHOCYTE–SPECIFIC ADHESION MOLECULE THAT REGULATES ANTIGEN RECEPTOR SIGNALING*
Tedder, T. F., Tuscano, J., Sato, S., & Kehrl, J. H. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.481 · Cited by 300
Crocker, P. R., Mucklow, S., Bouckson, V., McWilliam, A., Willis, A. C., Gordon, S., Milon, G., Kelm, S., & Bradfield, P. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06771.x · Cited by 270
Zhang, J., Raper, A., Sugita, N., Hingorani, R., Salio, M., Palmowski, M. J., Cerundolo, V., & Crocker, P. R. (2006) · Blood · doi:10.1182/blood-2005-09-3842 · Cited by 267
Nicoll, G., Ni, J., Liu, D., Klenerman, P., Munday, J., Dubock, S., Mattei, M.-G., & Crocker, P. R. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.48.34089 · Cited by 253
Phase I/II Trial of Epratuzumab (Humanized Anti-CD22 Antibody) in Indolent Non-Hodgkin’s Lymphoma
Leonard, J. P., Coleman, M., Ketas, J. C., Chadburn, A., Ely, S., Furman, R. R., Wegener, W. A., Hansen, H. J., Ziccardi, H., Eschenberg, M., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.01.082 · Cited by 253
CD22 ligation inhibits downstream B cell receptor signaling and Ca2+ flux upon activation
Sieger, N., Fleischer, S. J., Mei, H. E., Reiter, K., Shock, A., Burmester, G. R., Daridon, C., & Dörner, T. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37818 · Cited by 61
Genomic determinants of response and resistance to inotuzumab ozogamicin in B-cell ALL
Zhao, Y., Short, N. J., Kantarjian, H. M., Chang, T.-C., Ghate, P. S., Qu, C., Macaron, W., Jain, N., Thakral, B., Phillips, A. H., et al. (2024) · Blood · doi:10.1182/blood.2024023930 · Cited by 41
Metadata
- Authors
- Dörken, B., Moldenhauer, G., Pezzutto, A., Schwartz, R., Feller, A., Kiesel, S., & Nadler, L. M.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1986-06
- Volume
- 136
- Issue
- 12
- Pages
- 4470-4479
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1944128175
- Cited by
- 170
- References
- 0
- Type
- conference abstract
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.